Navigation Links
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
Date:8/27/2007

- Companies Will Jointly Conduct Phase III Development and

Commercialization of DGAT-1 Inhibitor Compounds -

NEW YORK, and PRINCETON, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) and Bristol-Myers Squibb Company (NYSE: BMY) ("companies") today announced that they have finalized a definitive agreement for the worldwide collaboration to research, develop and commercialize DGAT-1 inhibitors, a collaboration first announced on April 26, 2007. Pfizer's DGAT- 1 discovery program includes advanced pre-clinical compounds with potential applications for the treatment of metabolic disorders, including obesity and diabetes. The program also includes DGAT-1 inhibitors in-licensed by Pfizer from Bayer Pharmaceuticals Corporation in June 2006, including a pre-clinical compound (known as PF-04415060 or BAY 74-4113) originally discovered by Bayer.

Under terms of the agreement, Pfizer will be responsible for all research and early-stage development activities for the metabolic disorders program, and the companies will jointly conduct Phase III development and commercialization activities.

"The worldwide incidence of metabolic disorders is increasing rapidly, and complications from diabetes and obesity are leading causes of disability and mortality globally. DGAT-1 inhibitors have shown promise in pre-clinical testing, and this research program has potential to yield several compounds that may improve treatment options for patients," said
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Mirus Bio, Pfizer enter multimillion-dollar research agreement
2. Pfizer-Pharmacia Fallout Gives Celltech A CEO
3. Sale of Norlight Telecommunications is finalized
4. WARF enters licensing agreements for stem cell products
5. Quick peeks, Clawback Agreements, and the rules of electronic discovery
6. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
7. WARF expands license agreement with Advanced Cell Technology
8. Lucigen Corp. enters global licensing agreement
9. GE Healthcare enters agreement with Canadian health authority
10. New angel capital centered on GenTel agreement with big pharma
11. Prodesse enters patent agreement with Roche

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/5/2009)...-FirstCall/ -- Wound Management Technologies, Inc.... a Letter of Intent to purchase all healthcare-rel...OTC Bulletin Board: VHGI). The deal provides for V...000 shares of WNDM and a royalty agreement for rev...y being acquired from VHGI. WNDM closed at $2.00...
(Date:11/5/2009)...irstCall/ -- WaferGen Biosystems, Inc. (OTC Bullet...he-art genetic analysis systems, today announced t...y,s Scientific Advisory Board. His career has bee...olecular diagnostics for cancer detection and othe...ional biology systems for several biotechnology co...
(Date:11/5/2009)...Newswire-Asia-FirstCall/ -- BMP Sunstone,Corporati...y") today announced,that the Company plans to rele..., November 9, 2009, after the market closes. ,,...:00 pm ET on November 9, 2009,to discuss third qua...by,dialing 1-888-713-4211 or 1-617-213-4864 for in...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...elebrates 50th Anniversary -- , , LEXINGTON, Mass...ldwide developer, manufacturer and distributor of ...s and services, is celebrating the anniversary dat...pany launched its "50 and Forward" celebration in ...iversary year with events that reflect on IL,s 50 ...
...A ANA, Calif., Jan. 12 ,Abbott ( NYSE: ABT ) and A...ced,today a definitive agreement for Abbott to acq...ansaction value of approximately $2.8 billion, inc...g. Based in Santa Ana, Calif., AMO,is a global le...ts: cataract,surgery, laser vision correction (LAS...
...icrobia Precision Engineering,Inc. (Microbia) anno...the,company as Director of North American Sales. I...esponsible for developing and maintaining business...ss North America. , "Chuck Walton is a highly ...pplement industries with an exceptional 25-year sa...
Other Biology Technology:2009 Marks 50 Years of Innovative 'Firsts' for Instrumentation Laboratory 22009 Marks 50 Years of Innovative 'Firsts' for Instrumentation Laboratory 32009 Marks 50 Years of Innovative 'Firsts' for Instrumentation Laboratory 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Microbia PE Adds Nutritional Ingredient Industry Veteran Charles Walton to Senior Management Team 2
(Date:11/8/2009)...CATION DESIGNED FOR ADULTS WITH INTELLECTUAL DISAB...n Indiana University study involving adults with i...reased their personal health knowledge after takin...with ID, an internationally accepted term for ment...ity, physical inactivity and preventable chronic d...
(Date:11/6/2009)...he 150th anniversary this month of the publication...te of Biological Sciences (AIBS) is publishing ope...Darwin and his historic insights into evolution. ,...ersity of California, Berkeley, and James T. Costa... "Ten Myths About Charles Darwin," appeared in the...
(Date:11/6/2009)...ov. 6 Auburn Hills, MI-based Law E... installing its locker system and patent-pending B....S. Department of Health and Human Services, Natio...MD. The locker system will support the NIH,s enti... our nation,s medical research agency. The projec...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Mormon Tabernacle Choir Benefit Concert Helps Colorado Disabled Iraqi War Veteran and National Sports Center for the Disabled Athletes 48018 1Mormon Tabernacle Choir Benefit Concert Helps Colorado Disabled Iraqi War Veteran and National Sports Center for the Disabled Athletes 48018 2Antiabortion Advocate Appointed to Senior Position at HHS 48015 1Antiabortion Advocate Appointed to Senior Position at HHS 48015 2Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 1Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 2Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 3Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 4
...ighly addictive, researchers have also shown the d... has launched efforts to develop nicotine-like dru...Parkinson’s diseases, schizophrenia, and attention...n designing such drugs has been that little was kn... exerts its learning-enhancing effects. , Now, ...
...estigates a bitter row over a scientific paper tha...rutiny once again. , The dispute has pitted a youn... Cha, a fertility specialist and one of the most p...ech supremacy, writes journalist Jonathan Gornall.... to recover scientific credibility in the wake of ...
...g the physics of hearing have found an underlying ...nceptual connection between deafness and the organ...-panel displays. , Within the cochlea of the inner...brate. These vibrations stimulate hair cells, whic... to the brain. , Researchers have now learned th...
Other Biology News:Mechanism of nicotine's learning effects explored 2Row over study puts Korea's scientific community under scrutiny again 2Scientists identify molecular cause for one form of deafness 2
Vented Caps for 75 cm2 Flasks from BD Biosciences - Discovery Labware
BD Falcon Center-well Organ Culture Dish, In Vitro Fertilization Dish from BD Biosciences - Discovery Labware
BD BioCoat Gelatin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Matrigel Matrix 100 mm Culture Dishes for Hepatocytes from BD Biosciences - Discovery Labware
Biology Products: